MAGNISENSE

magnisense-logo

Magnisense conçoit, développe et commercialise des tests de diagnostic d'urgence pour les maladies cardio-vasculaires à partir de sa technologie MIAtek® et de son instrument de diagnostic propriétaires

#SimilarOrganizations #People #Financial #Website #More

MAGNISENSE

Social Links:

Industry:
Health Care Health Diagnostics Medical

Founded:
2003-01-01

Address:
Paris, Ile-de-France, France

Country:
France

Website Url:
http://www.magnisense.com

Total Employee:
1+

Status:
Active

Contact:
+33145628000

Email Addresses:
[email protected]

Total Funding:
11.7 M EUR

Technology used in webpage:
SPF Google Maps Google Maps API OVH Thickbox OVH DNS


Similar Organizations

advanced-cell-diagnostics-logo

Advanced Cell Diagnostics

Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.

akebia-therapeutics-logo

Akebia Therapeutics

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

mediquo-logo

MediQuo

Spain’s 24-hour, 7-day-a-week medical chat application.

metabolomic-diagnostics-logo

Metabolomic Diagnostics

Metabolomic Diagnostics specializes in the development of novel biomarker based diagnostic solutions for complex diseases

xrapid-logo

xRapid

xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence.

Current Employees Featured

stig-visti-andersen_image

Stig Visti Andersen
Stig Visti Andersen CEO @ Magnisense
CEO
2019-04-01

Founder


ingmar-adlerberg_image

Ingmar Adlerberg

Investors List

victor-douce_image

Victor Douce

Victor Douce investment in Venture Round - Magnisense

minv_image

Minv

Minv investment in Venture Round - Magnisense

concorde-capital_image

Concorde Capital

Concorde Capital investment in Venture Round - Magnisense

meusinvest_image

Meusinvest (Noshaq)

Meusinvest (Noshaq) investment in Venture Round - Magnisense

provestis_image

Provestis

Provestis investment in Venture Round - Magnisense

concorde-capital_image

Concorde Capital

Concorde Capital investment in Venture Round - Magnisense

provestis_image

Provestis

Provestis investment in Venture Round - Magnisense

bpifrance_image

Bpifrance

Bpifrance investment in Grant - Magnisense

Official Site Inspections

http://www.magnisense.com

Unable to get host informations!!!

Loading ...

More informations about "Magnisense"

Magnisense - Crunchbase Company Profile & Funding

Magnisense conçoit, développe et commercialise des tests de diagnostic d'urgence pour les maladies cardio-vasculaires à partir de sa technologie MIAtek® et de son instrument de …See details»

Magnisense Company Profile - Office Locations, Competitors, …

Magnisense is a company that designs, develops, and commercializes diagnostic tests for cardiovascular diseases. It offers MIAtek technology that enables to relocate emergency tests …See details»

Magnisense | VentureRadar

Magnisense VentureRadar profile. Find out more about Magnisense including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»

Magnisense SE Management Team | Org Chart - RocketReach

In line with its vision of "Improving emergency diagnosis, saving lives" , Magnisense is aiming at reinventing immuno-assays by providing healthcare professionals with simple, reliable and …See details»

Magnisense SE - Life-Sciences-Europe.com

Jan 1, 2010 · Magnisense is a privately held med-tech company that designs, develops, registers and markets rapid, mobile and connected diagnostic tests for heart diseases. After several …See details»

Magnisense SE - Company Profile and News - Bloomberg Markets

Magnisense SE manufactures diagnostic equipments. The Company develops magnetic immunoassays tests for detection of proteins, viruses, bacteria in biological and food samples. …See details»

Magnisense SE - Company Profile & Staff Directory - ContactOut

In line with its vision of "Improving emergency diagnosis, saving lives" , Magnisense is aiming at reinventing immuno-assays by providing healthcare professionals with simple, reliable and …See details»

Magnisense SE | Top MedTech Solution Company in Europe-2018

Governed by a mission to help build the medicine of tomorrow by improving emergency diagnosis, Magnisense emphasizes early diagnosis of myocardial infarction to quickly guide and initiate …See details»

Magnisense - Funding, Financials, Valuation & Investors

Magnisense is funded by 6 investors. Victor Douce and Minv are the most recent investors. Which investors participated in the most funding rounds?See details»

Magnisense - Medical Companies

Magnisense has developed and demonstrated a novel diagnostic technology which promises to revolutionize the immunoassay diagnostic test. The dramatic performance improvement which …See details»

Magnisense - Contacts, Employees, Board Members, Advisors

Find more contact data in Search! Magnisense has 1 current employee profile, CEO Stig Visti Andersen.See details»

Magnisense SE: Contact Details and Business Profile

Magnisense SE is a Medical Devices, Medical Testing & Clinical Laboratories, and Health Care company_reader located in Paris, ÃŽle-De-France with $5 million in revenue and 7 employees. …See details»

Magnisense Raises €5.5 Million To Better Diagnose ... - BioSpace

Nov 24, 2015 · Magnisense develops robust, portable and economical quantitative blood tests used to diagnose myocardial infarction in 15 minutes. Following current care procedures at the …See details»

Magnisense - Emerald Insight

Apr 3, 2007 · Magnisense develops and markets a new generation of immunoassays for human and animal diagnostics, food safety and environmental protection. These innovative …See details»

Magnisense - Crunchbase

Companies like Magnisense include Zebra Medical Vision, Akebia Therapeutics, and Knopp Biosciences. Knopp Neurosciences is a drug discovery and development company working on …See details»

Magnisense's Cornerstone Patent Is Issued In The United States

Paris, July 8, 2010 – Magnisense, a developer of next generation bioassays for human and animal diagnostics, food safety and environmental protection, today announced that the US …See details»

Magnisense Raises €5.5 Million To Better Diagnose ... - BioSpace

Nov 24, 2015 · Magnisense's tests will save lives, improve therapeutic care for people having a myocardial infarction and reduce long-term hospital stays, lasting damage and the need for …See details»

Magnisense and Indicia Announce Joint Testing Platform for …

Feb 19, 2007 · Both Companies in collaboration have developed a platform for customers in the diagnostics industry to test solutions based on Magnisense's MIAtekâ„¢ technology.See details»

Magnisense - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Magnisense uses 10 technology products and services including HTML5, Apache Server, and Bootstrap, according to G2 Stack. Magnisense is actively using 4 technologies for its website, …See details»

Heart Disease Diagnostics Firm Magnisense Raises €5M

Oct 26, 2018 · The firm said that the funding could boost the presence of its cardiovascular test already on the market in Europe and support the development of others.See details»

linkstock.net © 2022. All rights reserved